International Conference on Hematology and Blood Disease
ICHBD
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest research and clinical advancements in the diagnosis and treatment of hematologic malignancies. Emphasis will be placed on novel therapeutic strategies and their implications for patient outcomes.
SDG 3
SDG 4
This session will focus on the intersection of hematology and immunology, highlighting cutting-edge research in immune responses related to blood disorders. Discussions will include the role of immune therapies in managing hematologic diseases.
SDG 3
SDG 9
This track will delve into the pathophysiology of thrombosis and hemostasis, as well as current management strategies. Participants will examine recent findings that inform clinical practice and improve patient care.
SDG 3
SDG 4
This session will cover the latest advancements in stem cell research and their applications in treating blood disorders. Topics will include stem cell transplantation and regenerative medicine approaches.
SDG 3
SDG 9
This track will address contemporary diagnostic techniques and management strategies for various blood disorders. Emphasis will be placed on integrating new technologies into clinical practice.
SDG 3
SDG 4
This session will provide an overview of the relationship between blood disorders and oncology, focusing on the challenges and advancements in treating co-existing conditions. Discussions will include case studies and emerging therapies.
SDG 3
SDG 4
This track will highlight the latest innovations in drug development specifically targeting hematologic conditions. Participants will discuss the drug discovery process, clinical trials, and regulatory challenges.
SDG 3
SDG 9
This session will explore the evolving field of transfusion medicine, including best practices and innovations in blood product management. Topics will cover safety, efficacy, and ethical considerations in transfusion.
SDG 3
SDG 4
This track will examine the impact of advanced technologies on hematology research, including genomics, proteomics, and bioinformatics. Participants will discuss how these technologies are shaping the future of blood-based products.
SDG 3
SDG 9
This session will focus on the lymphatic system's role in hematology, exploring diseases associated with lymphatic dysfunction. Discussions will include diagnostic challenges and therapeutic approaches.
SDG 3
SDG 4
This track will emphasize the importance of multidisciplinary collaboration in the management of hematological disorders. Participants will share insights on integrating various specialties to enhance patient care and outcomes.
SDG 3
SDG 4